Welltica+ on MSN
Diabetes medication may reduce risk of eye disease by 37 percent
A common medication may have an unexpected effect on a serious eye condition, new research suggests.
Prevent Blindness, the nation's leading patient advocacy organization dedicated to preventing blindness and preserving sight, has declared March 23-29, 2026, as its first-ever Keratoconus Week. The ...
Metformin use in people with diabetes was linked to a significantly lower risk of developing intermediate age-related macular degeneration.
In its complete response letter, the FDA said Aldeyra had failed to demonstrate reproxalap’s efficacy in adequate and ...
With the number of diabetes cases surging across India, doctors warn that a silent epidemic of diabetes-related vision loss is emerging, particularly among younger adults. Lack of awareness, delayed ...
We present one of the first comprehensive evaluations of predictive information derived from retinal fundus photographs, illustrating the potential and limitations of readily accessible and low-cost ...
March 17 (Reuters) - The U.S. Food and Drug Administration declined to approve Aldeyra Therapeutics' drug for a type of eye ...
A new wireless eye implant restored reading vision in some blind adults, allowing many patients to recognize letters and ...
With the singular exception of punctal or canalicular occlusion, when we are talking about in-office dry eye disease ...
Zacks Investment Research on MSN
ALDX crashes 71% as FDA issues third CRL for dry eye disease drug NDA
Shares of Aldeyra Therapeutics ALDX plunged 70.7% on Tuesday after the company announced receiving a Complete Response Letter (CRL) from the FDA for a third time for the new drug application (NDA) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results